Companies: 10,795·Total market cap: $144.5T
Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

KKPCFOTCHealthcare● Active
$26.78
+$0.78(+3.00%)
Market Cap$1.0B
P/E Ratio
52W High$28.121
52W Low$22.3
Overview

Kaken Pharmaceutical Co., Ltd. (KKPCF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · KKPCF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$56.33kkpcf eps ttm · kkpcf earnings per shareEarnings history
PE Ratio (TTM)0.5×kkpcf pe ratio ttm · kkpcf price to earningsPE Ratio deep dive
Revenue (TTM)$77.3Bkkpcf revenue ttm · kkpcf annual revenueFull revenue history
Dividend Yield3.64%does kkpcf pay dividends · kkpcf dividend yieldDividend history
Shares Outstanding37.9Mkkpcf shares outstanding · kkpcf floatShares outstanding history
Next EarningsJul 30, 2026Est.kkpcf earnings date · kkpcf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2026Revenue$77.35B▼ 17.74% YoY
202420252026
kaken pharmaceutical co., ltd. revenue · kkpcf revenue 2026
FY 2026Net Income$2.16B▼ 84.53% YoY
202420252026
kaken pharmaceutical co., ltd. net income · kkpcf profit 2026
FY 2026EPS$57.52▼ 84.26% YoY
202420252026
kkpcf eps · kaken pharmaceutical co., ltd. earnings per share 2026
TTM:Revenue: $77.30BNet Income: $2.16BEPS: $56.33View income statement →

Stock Performance

Full History
1D+3.00%
1W+3.00%
1M+3.00%
3M+3.00%
YTD+13.23%
1Y-4.66%
5Y-32.78%

About Kaken Pharmaceutical Co., Ltd.

CEOHiroyuki Horiuchi
IPO DateDec 9, 2020
Employees1,135
CountryJP

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, su…

what is kaken pharmaceutical co., ltd. · kkpcf stock overview · kaken pharmaceutical co., ltd. company profile · who is kaken pharmaceutical co., ltd. ceo · kkpcf OTC · kaken pharmaceutical co., ltd. headquarters · kaken pharmaceutical co., ltd. business segments

About Stock Overview & Key Data

Kaken Pharmaceutical Co., Ltd. (KKPCF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Dec 9, 2020. As of the latest trading session, KKPCF stock price is $26.78, with a market capitalization of $1.0B. The stock has returned -4.66% over the past 12 months and +13.23% year-to-date.

In fiscal year 2026, Kaken Pharmaceutical Co., Ltd. reported revenue of $77.4B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Kaken Pharmaceutical Co., Ltd. (KKPCF) stock price is $26.78. The stock is traded on OTC under the ticker symbol KKPCF. The 52-week range is $22.30 – $28.12.

KKPCF stock priceKKPCF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice